2025 ASCCP Scientific Meeting on Anogenital & HPV-Related Diseases

2025 ASCCP Scientific Meeting on Anogenital & HPV-Related Diseases is organized by ASCCP and will be held from Apr 24 - 26, 2025 at Sheraton San Diego Resort, San Diego, California, United States of America.

In-Person Meeting  —  April 24-26, 2025, San Diego, CA
Online Meeting  — May 5-June 30, 2025, online/on-demand recordings

Meeting Overview:
Join us at the ASCCP 2025 Scientific Meeting, themed “Moving from Concepts to Caring.” This event is about turning innovative ideas into compassionate healthcare practices.

What to Expect:

• Innovations, Technologies, and Concepts: Discover the cutting-edge advancements that are reshaping the landscape of cervical pathology and it’s clinical management. From breakthrough research to innovative technologies, this session will ignite your imagination and inspire new possibilities.
• Management Guidelines: Stay ahead of the curve with the latest evidence-based management guidelines. Learn from the experts about best practices and standards that are revolutionizing patient care, ensuring you’re equipped to deliver top-notch healthcare.
• Implementation Science: Dive into the science of putting theory into practice. This focus area will explore strategies to effectively implement new findings and innovations in real-world settings, bridging the gap between research and patient care.

Don't miss this immersive experience with insightful presentations and engaging discussions.

Description:
Through an array of educational offerings, the 2025 ASCCP Scientific Meeting on Anogenital and HPV-Related Diseases will bring together healthcare professionals from different backgrounds and experience levels who are interested in staying informed about the latest research dedicated to improving clinical outcomes and to reducing the burden of anogenital and HPV-related diseases around the world.

Educational Objectives:

• Integrate into practice new insights from the latest research on prevention, diagnosis and management of anogenital and HPV-related diseases.
• Describe the biology, epidemiology, natural history, and immune response to HPV, as well as the societal costs associated with HPV infections.
• Apply consensus guidelines for cervical cancer screening and management of cervical abnormalities to the general population as well as those in special circumstances.
• Apply novel screening and management strategies to underserved and under-screened individuals (transgender, incarcerated, etc.).
• Apply colposcopy to the diagnosis and management of anogenital and HPV-related diseases in ways that reflect its usefulness and maximum benefits while minimizing potential harms.
• Diagnose and treat HPV-related diseases including those that affect the cervix, vagina, vulva, anus, and head/neck. .
• Identify strategies for prevention and screening of HPV-associated oropharyngeal disorders.
• Identify novel and experimental uses of therapeutic and prophylactic HPV vaccines, including the use of “catch-up” HPV immunization.
• Apply HPV testing and relevant diagnostic tests to clinical practice in a directed, evidence-based, cost-effective manner.
• Describe the vaginal microbiome and describe its impact on HPV clearance.
• Recognize the impact of implicit bias on patient care and learn techniques to identify and address this bias.
• Apply data on HPV ecology to screening and management of patients who are postmenopausal.
• Manage positive cytology and HPV test results, high risk HPV genotype results, and histologically confirmed anogenital neoplasia, reflecting current and future patient risk of high grade neoplasia.